- Home
- RAC vs CLLS Comparison
RAC vs CLLS Comparison
Compare RAC & CLLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAC
- CLLS
- Stock Information
- Founded
- RAC 2024
- CLLS 1999
- Country
- RAC United States
- CLLS France
- Employees
- RAC N/A
- CLLS N/A
- Industry
- RAC
- CLLS Biotechnology: Pharmaceutical Preparations
- Sector
- RAC
- CLLS Health Care
- Exchange
- RAC Nasdaq
- CLLS Nasdaq
- Market Cap
- RAC 302.3M
- CLLS 299.0M
- IPO Year
- RAC 2025
- CLLS 2007
- Fundamental
- Price
- RAC $10.24
- CLLS $3.17
- Analyst Decision
- RAC
- CLLS Buy
- Analyst Count
- RAC 0
- CLLS 1
- Target Price
- RAC N/A
- CLLS $4.00
- AVG Volume (30 Days)
- RAC 91.0K
- CLLS 77.4K
- Earning Date
- RAC 01-01-0001
- CLLS 11-03-2025
- Dividend Yield
- RAC N/A
- CLLS N/A
- EPS Growth
- RAC N/A
- CLLS N/A
- EPS
- RAC N/A
- CLLS N/A
- Revenue
- RAC N/A
- CLLS $63,438,000.00
- Revenue This Year
- RAC N/A
- CLLS N/A
- Revenue Next Year
- RAC N/A
- CLLS $66.76
- P/E Ratio
- RAC N/A
- CLLS N/A
- Revenue Growth
- RAC N/A
- CLLS 223.09
- 52 Week Low
- RAC $9.87
- CLLS $1.10
- 52 Week High
- RAC $10.35
- CLLS $3.35
- Technical
- Relative Strength Index (RSI)
- RAC N/A
- CLLS 64.81
- Support Level
- RAC N/A
- CLLS $2.99
- Resistance Level
- RAC N/A
- CLLS $3.20
- Average True Range (ATR)
- RAC 0.00
- CLLS 0.17
- MACD
- RAC 0.00
- CLLS 0.03
- Stochastic Oscillator
- RAC 0.00
- CLLS 78.82
About RAC Rithm Acquisition Corp. Class A Ordinary Shares
Rithm Acquisition Corp is a blank check company.
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.